Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasia
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (2), 200-205
- https://doi.org/10.1016/0090-8258(90)90333-g
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Interleukin 2 production in lymphocyte cultures: a rapid test for cancer-associated immunodeficiency in malignant cervical neoplasiaCancer Letters, 1989
- Interleukin 2 and Alpha Interferon Induced in Vitro Modulation of Spontaneous Cell Mediated Cytotoxicity in Patients with Cancer of the Uterine Cervix Undergoing RadiotherapyActa Oncologica, 1989
- Immune function in malignant cervical neoplasia: A multiparameter analysisGynecologic Oncology, 1988
- Natural Cytotoxicity and Serum Blocking in Malignant Cervical NeoplasiaAmerican Journal of Reproductive Immunology, 1988
- Monoclonal Antibody Defined Phenotypes of Peripheral Blood Lymphocytes in Cancer of the Uterine CervixAmerican Journal of Reproductive Immunology, 1987
- Long-term effects on the immune system following local radiation therapy for breast cancer. 4. Proliferative responses and induction of suppressor activity of the blood lymphocyte populationRadiotherapy and Oncology, 1986
- Defect in lectin-induce interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's DiseaseEuropean Journal of Cancer and Clinical Oncology, 1985
- Effect of Irradiation on Concanavalin A-Induced Suppression of Mitogen Responses in Human Lymphocyte CulturesInternational Archives of Allergy and Immunology, 1982
- Studies on T lymphocyte activation I. Requirements for the mitogen‐dependent production of T cell growth factorsEuropean Journal of Immunology, 1979
- The Concept of Immunological SurveillancePublished by S. Karger AG ,1969